Zestra Laboratories, Inc., a privately-held
research and development company announces its
new “Passionate Packaging” of Zest®ra™ Feminine
Arousal Fluid, designed to bring the recently patented
new product to drug and cosmetic store shelves
nationwide. The purple and orange box with a drop of
dew on a petal contains 9 individual single use foil
packets (sachets).
The topical application of Zestra®™ combined with
tender massage helps to lubricate delicate tissue. The
formulation has been found to significantly increase
arousal, pleasure and satisfaction in women.
Clinical study results for Zestra®™ were first reported in
Boston at the prestigious International Society for the
Study of Women's Sexual Health (ISSWSH) and were
published in two respected peer-reviewed medical
journals -- The Journal of Sex & Marital Therapy and
Drugs.
Sexual problems are more common in women than
men, with 43 percent of women age 18 to 59 reporting
a prolonged problem compared with 31 percent of
men, according to a study published in the Journal of
the American Medical Association in 1999.
Medical experts indicate that menopause,
hysterectomy, SSRI antidepressants, birth control pills,
rapid weight loss and other circumstances often produce female sexual difficulties. Nonprescription
Zestra®™ Feminine Arousal Fluid is the “first-line” choice of women’s healthcare
professionals and pharmacists for increasing female sexual pleasure and satisfaction.
According to a recent CBS MarketWatch report, the sales opportunity waiting to be captured in
the female sexual satisfaction market is estimated at $1.5 to $3 billion.
For additional information visit: www.zestraforwomen.com or call 1.877.493.7872.
Download the PDF version.
